Senior Computational Biologist (Remote) at Output Biosciences

Remote

Apply Now

$125,000 – $210,000Compensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Artificial Intelligence, HealthcareIndustries

Skills

Key technologies and capabilities for this role

PythonComputational BiologyStructure PredictionMolecular DockingVirtual ScreeningProtein Language ModelsChemical Language ModelsMachine LearningData ScienceBiological ReasoningGenerative ModelsAI

Questions & Answers

Common questions about this position

Is this Senior Computational Biologist role remote?

Yes, the role is remote, but you will be expected to travel periodically for in-person team meetings at our NYC HQ.

What are the required qualifications for this position?

Candidates need a PhD in a biological field and strong programming skills in Python, experience with computational biology tools such as structure prediction, molecular docking and virtual screening, and experience working with Protein or Chemical Language Models.

What is the salary or compensation for this role?

This information is not specified in the job description.

What is the company culture like at Output Biosciences?

The company fosters a culture of ownership with passionate individuals who take pride in their contributions, emphasizes unwavering commitment to excellence, and values practicality and results-oriented thinking.

What makes a strong candidate for this Senior Computational Biologist role?

Strong candidates exhibit a proactive approach to problem-solving, a mature mindset in ambiguous situations, excellent communication skills, and passion for using data science to unlock biology, along with enjoying collaborative work in a fast-paced startup.

Output Biosciences

Develops preventative therapies for chronic diseases

About Output Biosciences

Output Biosciences focuses on developing preventative therapies aimed at extending human healthspan by addressing chronic diseases such as diabetes and heart disease. The company combines biotechnology with artificial intelligence to create therapies that can be discovered and manufactured more quickly and safely than traditional methods. This allows them to bring new treatments to market in just a few months, which is much faster than the usual drug development process. Their main clients include healthcare providers, pharmaceutical companies, and research institutions seeking effective solutions for chronic disease management. Output Biosciences differentiates itself by leveraging computational biology to streamline therapy development and commercialization, generating revenue through partnerships and licensing. The goal of Output Biosciences is to fundamentally change healthcare by preventing chronic diseases before they occur.

New York City, New YorkHeadquarters

2020Year Founded

$125KTotal Funding

PRE_SEEDCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1-10Employees

Risks

Increased competition from AI-driven biotech startups threatens market share.

Regulatory scrutiny on AI applications may delay approval processes.

Rapid technological advancements may render current methods obsolete without continuous innovation.

Differentiation

Output Biosciences integrates AI and computational biology for rapid therapy development.

The company focuses on preventative therapeutics to extend human healthspan.

Output Biosciences accelerates drug development timelines, bringing therapies to market in months.

Upsides

Growing interest in AI-driven drug discovery boosts investment and partnerships.

Rise of personalized medicine creates opportunities for tailored AI-integrated therapies.

FDA's acceptance of AI-driven drug development enables faster regulatory pathways.

Land your dream remote job 3x faster with AI

Try Jobo Free